Eosinophila during fludarabine treatment of chronic lymphocytic leukemia

Annals of Hematology

Volumn 78, Issue 10, 1999, Pages 475-477

  Sezer, O ^a   Schmid, P ^a   Hallek, M ^b   Schweigert, M ^a   Beinert, T ^a   Langelotz, C ^a   Mergenthaler, H G ^a   Possinger, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic lymphocytic leukemia; Eosinophilia; Fludarabine; Purine analogues

Indexed keywords

CD4 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; PURINE DERIVATIVE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VIDARABINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; BONE MARROW; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; EOSINOPHIL; EOSINOPHILIA; FEVER; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOMA; NAUSEA; NEUROTOXICITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VOMITING; CHEMICALLY INDUCED DISORDER; MALE; MIDDLE AGED; REVIEW;

AGED; ANTINEOPLASTIC AGENTS; EOSINOPHILIA; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; VIDARABINE;

EID: 0032589560     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050602     Document Type: Article

References (11)

1. Braess J, Reich K, Willert S, Strutz F, Neumann C, Hiddemann W, Wörmann B (1997) Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL). Ann Hematol 75:227-230
2. Eftekhari P, Lassoued K, Oksenhendler E, Scieux C, Clauvel JP (1998) Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia. Ann Hematol 76:225-226
3. Lärfars G, Udén-Blohmé AM, Samuelsson J (1996) Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies. Br J Haematol 94:709-712
4. Plunkett W, Gandhi V, Huang P, Robertson LE, Yang LY, Gregoire V, Estey E, Keating MJ (1993) Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. Semin Oncol 20:2-12
5. Pott-Hoeck C, Hiddemann W (1995) Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. Ann Oncol 6:421-433
6. Robak T, Blasinska-Morawiec M, Krykowski E (1992) Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Acta Haematol Pol 23:285-290
7. Robak T, Blasinska-Morawiec M, Krykowski E, Hellmann A, Lewandowski K, Dmoszynska A, Adamczyk-Cioch M, Kazinüerczak M, Trepinska E, Dwilewicz-Trojaczek M, Kuratowska Z, Skotnicki AB, Nowak WS, Zdziarska B, Urasinski I (1997) 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases. Eur J Haematol 59:216-220
8. Rothenberg ME (1998) Eosinophilia. N Engl J Med 338:1592-1600
9. Rutella S, Sica S, Rumi C, Martucci R, Etuk B, De Stefano V, Testa U, Leone G, Peschle C (1996) Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. Br J Haematol 92:426-428
10. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101-3109
11. Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD (1997) Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. J Clin Oncol 15:458-465